Predominant role of NF-κB p65 in the pathogenesis of chronic intestinal inflammation

Immunobiology

Volumn 198, Issue 1-3, 1997, Pages 91-98

  Neurath, Markus F ^a   Pettersson, Sven ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHRONIC INFLAMMATION; COLITIS; DOWN REGULATION; ENTERITIS; FEMALE; MOUSE; MUCOSA INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0031434763     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(97)80030-7     Document Type: Article

References (13)

1. PODOLSKY, D. K. 1991. Inflammatory bowel disease. New Engl. J. Med. 325: 928.
2. NEURATH, M. F., and K.-H. MEYER ZUM BÜSCHENFELDE. 1996. Protective and pathogenic roles of cytokines in inflammatory bowel diseases. J. Invest. Med., in press.
3. SADLACK, B., H. MERZ, H. SCHORLE, A. SCHIMPL, A. C. FELLER, and I. HORVAK. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75: 253.
4. KÜHN, R., J. LÖHLER, D. RENNICK, K. RAJEWSKY, and W. MÜLLER. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263.
5. POWRIE, F., M. W. LEACH, S. MAUZE, S. MENON, L. B. CADDLE, and R. L. COFFMAN. 1994. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1: 553.
6. NEURATH, M. F., I. FUSS, B. KELSALL, E. STUBER, and W. STROBER. 1995. Antibodies to IL-12 abrogate established experimental colitis in mice. J. Exp. Med. 182: 1280.
7. NEURATH, M. F., I. FUSS, B. KELSALL, D. H. PRESKY, W. WAEGELL, and W. STROBER. 1996. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. J. Exp. Med. 183: 2605.
8. BAEUERLE, P. A., and T. HENKEL. 1994. Function and activation of NF-κB in the immune system. Ann. Rev. Immunol. 12: 141.
9. FINCO, T. S., and A. S. BALDWIN. 1995. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity 3: 263.
10. LENARDO, M. J., and D. BALTIMORE. 1989. NF-κB: a pleiotropic activator of inducible and tissue specific gene control. Cell 58: 227.
11. NEURATH, M. F., S. PETTERSSON, K.-H. MEYER ZUM BÜSCHENFELDE, and W. STROBER. 1996. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates experimental colitis in mice. Nature Med. 2: 998.
12. LIBERMANN, T. A., and D. BALTIMORE. 1990. Activation of interleukin-6 gene expression through the NF-κB transcription factor. Mol. Cell. Biol. 10: 2327.
13. SHAKHOV, A. N. 1990. κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages. J. Exp. Med. 171: 35.